Category: Top Story
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, OpenAI Valuation, Challenger Layoffs, and Market Movers in Focus
U.S. stock futures were mostly higher Thursday as disappointing private payroll data fueled hopes for additional Federal Reserve interest rate cuts, even as a prolonged U.S. government shutdown continued to cloud sentiment. ChatGPT developer OpenAI reportedly reached a $500 billion valuation following a new secondary share sale, making it the world’s most valuable startup. Meanwhile,…
-
Oil climbs slightly as Russia sanctions fears offset supply concerns
Oil prices inched higher on Thursday after a three-day slide, buoyed by worries over potential tighter sanctions on Russian crude, though abundant supply kept gains in check. At 06:31 GMT, Brent futures rose 20 cents, or 0.31%, to $65.55 a barrel, while U.S. West Texas Intermediate (WTI) gained 20 cents, or 0.32%, to $61.98 a…
-
Gold Nears Record Levels as US Shutdown and Fed Rate Cuts Support Demand
Gold prices held near record highs on Thursday in Asian trading, buoyed by safe-haven buying amid the ongoing U.S. government shutdown and increasing expectations of further Federal Reserve interest rate reductions. The precious metal climbed to multiple highs this week after the U.S. government partially closed following Congress’s failure to pass a spending bill. The…
-
Dollar Slips Amid U.S. Government Shutdown, Euro Gains Momentum
The U.S. dollar continued its slide Thursday, extending losses into a fourth consecutive session as traders consider the effects of the ongoing U.S. government shutdown and the likelihood of further Federal Reserve rate cuts. By 04:15 ET (08:15 GMT), the Dollar Index, which tracks the greenback against a basket of six major currencies, fell 0.1%…
-
The gold junior with a fully permitted mill – Ready for gold production in 2026?
Looking for gold juniors with real assets and near-term production? In this exclusive interview, we speak with Kal Malhi, Chairman of LaFleur Minerals (CSE:LFLR)), about their flagship Swanson Gold Project and the fully-permitted Beacon Gold Mill in Val-d’Or, Québec → a setup that may position the company to enter gold production by early 2026. Key highlights:…
-
Meta to leverage AI chatbot interactions for ad personalization on Facebook and Instagram
Meta Platforms Inc. (NASDAQ:META) plans to use user interactions with its AI chatbot to tailor content and advertisements on Facebook and Instagram, according to a Bloomberg News report. Starting December 16, the AI chatbot will influence the posts and ads users see. For instance, a user asking the chatbot for help planning a family vacation…
-
Ford posts 8.2% rise in U.S. third-quarter vehicle sales
Ford Motor Company (NYSE:F) reported an 8.2% increase in U.S. sales for the third quarter of 2025, delivering a total of 545,522 vehicles compared to the same period last year. The automaker noted seven consecutive months of growth across trucks, SUVs, and electrified vehicles. The F-Series trucks sold 207,732 units in Q3, marking a 4.7%…
-
CCSC Technology shares drop after $0.60 public offering pricing
CCSC Technology International Holdings Ltd (NASDAQ:CCTG) saw its stock fall 16.9% on Wednesday after the Hong Kong-based interconnect products company announced it had priced its public offering at $0.60 per share. The offering includes 11,766,627 Class A ordinary shares, each accompanied by two warrants allowing the purchase of additional Class A shares. The warrants carry…
-
Chijet shares surge after $1 billion private placement commitment
Chijet Motor Company, Inc. (NASDAQ:CJET) saw its stock skyrocket 181.4% on Wednesday following news that the company signed a Memorandum of Understanding with institutional investors for an expanded private placement of up to $1 billion. The commitment represents a massive increase from Chijet’s earlier $20 million private placement announced on September 26, marking a 50-fold…
-
Fortress Biotech shares tumble after FDA rejection of Menkes treatment
Fortress Biotech Inc (NASDAQ:FBIO) saw its stock collapse 33.7% on Wednesday after the company announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for its Menkes disease therapy. The FDA declined the New Drug Application for CUTX-101 (copper histidinate), citing deficiencies in current Good Manufacturing Practice (cGMP) at the…